Literature DB >> 30483955

Evaluation of tumor-infiltrating lymphocytes in osteosarcomas of the jaws: a multicenter study.

Pollianna Muniz Alves1,2, José Alcides Almeida de Arruda3, Diego Antônio Costa Arantes2, Sara Ferreira Santos Costa3, Lucas Lacerda Souza4, Hélder Antônio Rebelo Pontes4, Felipe Paiva Fonseca3, Ricardo Alves Mesquita3, Cassiano Francisco Weege Nonaka1, Elismauro Francisco Mendonça2, Aline Carvalho Batista5,6.   

Abstract

The aim of the present study was to investigate the profile of tumor-infiltrating lymphocytes (TIL) in osteosarcomas of the jaws (OSJ). A total of 21 OSJ samples were analyzed in a retrospective and cross-sectional multicenter study. Immunohistochemistry was performed to determine the recognition of TIL such as CD4+, CD8+, granzyme B+ (GrB), programmed cell death protein+ (PD-1), and cytotoxic T lymphocyte-associated antigen 4+ (CTLA-4) in intratumoral and peripheral (stromal) regions. Positivity was determined based on the percentage and density of TIL+ per square millimeter [1 = absent (< 25 cells/mm2), 2 = low (25 to 130 cells/mm2), and 3 = high (> 130 cells/mm2)]. The association of TIL density with clinicopathologic data was determined by the Mann-Whitney test (p < 0.05). OSJ were positive for CD8+ cells in 45% (n = 9) of cases, for CD4+ cells in 30% (n = 6) of cases, and for CTLA-4+ in 4.8% (n = 1) of cases, with a score of 2 (low TIL) in all cases. All cases were negative for GrB and PD-1 (score 1). No association was observed between immune infiltrate and clinicopathologic findings. OSJ showed a microenvironment with low TIL, including failure of effectiveness of the antitumor immune response (absence of GrB+ cells), and few cells exhibited immunotherapeutic targets, such as CTLA-4 and PD-1.

Entities:  

Keywords:  Immunotherapy; Oral cancer; Osteosarcoma; Tumor microenvironment; Tumor-infiltrating lymphocytes

Mesh:

Substances:

Year:  2018        PMID: 30483955     DOI: 10.1007/s00428-018-2499-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  3 in total

1.  Tumor-Infiltrating Lymphocytes and Cancer Markers in Osteosarcoma: Influence on Patient Survival.

Authors:  José Manuel Casanova; Jani-Sofia Almeida; John David Reith; Luana Madalena Sousa; Ruben Fonseca; Paulo Freitas-Tavares; Manuel Santos-Rosa; Paulo Rodrigues-Santos
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

2.  High Expression of TIM 3 and Galectin 9 on Immunohistochemistry Staining of Tumor Specimen at Diagnosis in Pediatric Patients with Ewing Sarcoma.

Authors:  Stephanie J Si; Gerald B Wertheim; David M Barrett
Journal:  J Cancer Immunol (Wilmington)       Date:  2021

3.  Development of an immune-related prognostic index associated with osteosarcoma.

Authors:  Chao-Dong Yin; Ying-Lan Hou; Xiao-Ren Liu; Yu-Sheng He; Xin-Ping Wang; Cheng-Jie Li; Xiao-Hong Tan; Jun Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.